Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EBT (2016 - 2026)

Healthequity has reported EBT over the past 14 years, most recently at $60.9 million for Q1 2026.

  • Quarterly results put EBT at $60.9 million for Q1 2026, up 103.26% from a year ago — trailing twelve months through Jan 2026 was $277.4 million (up 139.1% YoY), and the annual figure for FY2026 was $277.4 million, up 139.1%.
  • EBT for Q1 2026 was $60.9 million at Healthequity, down from $67.5 million in the prior quarter.
  • Over the last five years, EBT for HQY hit a ceiling of $78.0 million in Q3 2025 and a floor of -$43.8 million in Q1 2022.
  • Median EBT over the past 5 years was $21.1 million (2023), compared with a mean of $22.7 million.
  • Biggest five-year swings in EBT: tumbled 3161.18% in 2022 and later surged 371362.5% in 2024.
  • Healthequity's EBT stood at -$6.2 million in 2022, then surged by 441.21% to $21.1 million in 2023, then plummeted by 70.51% to $6.2 million in 2024, then skyrocketed by 986.07% to $67.5 million in 2025, then dropped by 9.82% to $60.9 million in 2026.
  • The last three reported values for EBT were $60.9 million (Q1 2026), $67.5 million (Q4 2025), and $78.0 million (Q3 2025) per Business Quant data.